EGFR is overexpressed in 40–70% of HCC and treatment of HCC cell lines, xenograft, and mouse models with EGFR inhibitors represses cell growth47,48, indicating that EGFR signaling is critical for HCC cell proliferation. Here, EGFR is linked to hepatocellular carcinoma.